Research Article

Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway

Figure 3

Rhodamine-123 (Rh123) efflux assay measuring MDR1 activity. (a) Flow cytometry analysis of intracellular accumulation of Rh123 in NCL overexpression cells with or without DDP treatment. (b) Mean fluorescence intensity of intracellular accumulation of Rh123. Results are mean ± SD of three independent experiments. .
(a)
(b)